Development of dichloroacetamide pyrimidines as pyruvate dehydrogenase kinase inhibitors to reduce cancer cell growth: synthesis and biological evaluation
Development of dichloroacetamide pyrimidines as pyruvate dehydrogenase kinase inhibitors to reduce cancer cell growth: synthesis and biological evaluation
Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation
作者:Shao-Lin Zhang、Xiaohui Hu、Wen Zhang、Kin Yip Tam
DOI:10.1021/acs.jmedchem.5b01828
日期:2016.4.14
Pyruvate dehydrogenase kinases (PDKs) have recently emerged as an attractive target for cancer therapy. Herein, we prepared a series of compounds derived from dichloroacetate (DCA) which inhibited cancer cells proliferation. For the first time, we have successfully developed DCA derived inhibitors that preferentially bind to the adenosine triphosphate (ATP) pocket of PDK isoform 1 (PDK1).
Development of dichloroacetamide pyrimidines as pyruvate dehydrogenase kinase inhibitors to reduce cancer cell growth: synthesis and biological evaluation
作者:Shao-Lin Zhang、Wen Zhang、Qingpin Xiao、Zheng Yang、Xiaohui Hu、Zhiyi Wei、Kin Yip Tam
DOI:10.1039/c6ra14060b
日期:——
The synthesis and biological assays were described herein to firstly identify a novel PDK1 inhibitor.